Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI

Corticosteroids are the mainstay of treatment for immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI), but the optimal duration of therapy has not been established. Prolonged use of corticosteroids can cause numerous adverse effects and may decrease progression-free survival among...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gupta, Shruti (VerfasserIn) , Garcia-Carro, Clara (VerfasserIn) , Prosek, Jason M. (VerfasserIn) , Glezerman, Ilya (VerfasserIn) , Herrmann, Sandra M. (VerfasserIn) , Garcia, Pablo (VerfasserIn) , Abudayyeh, Ala (VerfasserIn) , Lumlertgul, Nuttha (VerfasserIn) , Malik, A. Bilal (VerfasserIn) , Loew, Sebastian (VerfasserIn) , Beckerman, Pazit (VerfasserIn) , Renaghan, Amanda D. (VerfasserIn) , Carlos, Christopher A. (VerfasserIn) , Rashidi, Arash (VerfasserIn) , Mithani, Zain (VerfasserIn) , Deshpande, Priya (VerfasserIn) , Rangarajan, Sunil (VerfasserIn) , Shah, Chintan V. (VerfasserIn) , Seigneux, Sophie De (VerfasserIn) , Campedel, Luca (VerfasserIn) , Kitchlu, Abhijat (VerfasserIn) , Shin, Daniel Sanghoon (VerfasserIn) , Coppock, Gaia (VerfasserIn) , Ortiz-Melo, David I. (VerfasserIn) , Sprangers, Ben (VerfasserIn) , Aggarwal, Vikram (VerfasserIn) , Gente, Karolina (VerfasserIn) , Wanchoo, Rimda (VerfasserIn) , Murakami, Naoka (VerfasserIn) , Cortazar, Frank B. (VerfasserIn) , Reynolds, Kerry L. (VerfasserIn) , Sise, Meghan E. (VerfasserIn) , Soler, Maria Jose (VerfasserIn) , Leaf, David E. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 22, 2022
In: Journal for ImmunoTherapy of Cancer
Year: 2022, Jahrgang: 10, Heft: 9, Pages: 1-7
ISSN:2051-1426
DOI:10.1136/jitc-2022-005646
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1136/jitc-2022-005646
Verlag, lizenzpflichtig, Volltext: https://jitc.bmj.com/content/10/9/e005646
Volltext
Verfasserangaben:Shruti Gupta, Clara Garcia-Carro, Jason M Prosek, Ilya Glezerman, Sandra M Herrmann, Pablo Garcia, Ala Abudayyeh, Nuttha Lumlertgul, A Bilal Malik, Sebastian Loew, Pazit Beckerman, Amanda D Renaghan, Christopher A Carlos, Arash Rashidi, Zain Mithani, Priya Deshpande, Sunil Rangarajan, Chintan V Shah, Sophie De Seigneux, Luca Campedel, Abhijat Kitchlu, Daniel Sanghoon Shin, Gaia Coppock, David I Ortiz-Melo, Ben Sprangers, Vikram Aggarwal, Karolina Benesova, Rimda Wanchoo, Naoka Murakami, Frank B Cortazar, Kerry L Reynolds, Meghan E Sise, Maria Jose Soler, David E Leaf, ICPi-AKI Consortium
Beschreibung
Zusammenfassung:Corticosteroids are the mainstay of treatment for immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI), but the optimal duration of therapy has not been established. Prolonged use of corticosteroids can cause numerous adverse effects and may decrease progression-free survival among patients treated with ICPis. We sought to determine whether a shorter duration of corticosteroids was equally efficacious and safe as compared with a longer duration.
Beschreibung:Gesehen am 13.01.2023
Beschreibung:Online Resource
ISSN:2051-1426
DOI:10.1136/jitc-2022-005646